Dr. Neel D. Mehta, MD

Dr. Mehta practices at Cornell Anes Assoc in New York, New York.

Dr. Mehta's NPI, 1760641161, was assigned on June 2, 2008. Dr. Mehta graduated from Tufts University School Of Medicine in 2005. Dr. Mehta holds New York license 245312.

Dr. Mehta's primary practice is Cornell Anes Assoc, at 240 E 59th St, New York, NY 10022 in New York County. The practice phone is (212) 746-2846.

Dr. Mehta's primary practice is Cornell Anes Assoc in New York, New York. Dr. Mehta is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is Weill Cornell Physicians. Dmand AI also links Dr. Mehta to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mehta practices, 2 sites in all. Vendor and product names are available with a free account.

Interventional pain medicine is Dr. Mehta's primary specialty in the NPI Registry, under taxonomy code 208VP0014X. Dr. Mehta is board certified in anesthesiology by the American Board of Anesthesiology. Dmand AI has Dr. Mehta's licenses on file in 3 states: New York, New Jersey and Connecticut.

Dmand AI lists back pain injection, lower back pain, muscle pain, fibromyalgia, and limb pain, neck pain and spine problems, spinal stenosis and thoracic spine disorders among the conditions Dr. Mehta treats.

CMS data shows 5,171 Medicare services from Dr. Mehta across 24 procedure codes in 2024, for 501 Medicare patients. Medicare paid $233,861 for them.

CMS counts 501 Medicare patients who saw Dr. Mehta in 2024. The largest group is 75 to 84, with 216 patients. 75% of them have arthritis, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mehta's median patient age at 68, with 58% women.

In 2024, Dr. Mehta wrote 885 Medicare Part D claims for 226 patients. 93% of them were for generic drugs. CMS names the drug for 798 of them, across 21 drugs with 11 or more claims each, at $48,546 in total drug cost. In 2023, CMS named 895 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Mehta for performance year 2024, reported through an alternative payment model (APM). Dr. Mehta accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mehta as offering telehealth.

Dmand AI links 46 papers to Dr. Mehta, published from 2014 to 2025. 2019 was the busiest year, with 5. The most frequent topics are Analgesics, Opioid, Chronic Pain and Pain Management. Dr. Mehta has published most often in Curr Pain Headache Rep. Dr. Mehta's most frequent co-authors are Amitabh Gulati, MD, Dawood Sayed, MD and Rohit Sanjeev Aiyer, MD.

Dmand AI links Dr. Mehta to 1 clinical trial. Conditions studied include post laminectomy syndrome and Failed Back Surgery Syndrome.

CMS Open Payments shows 941 general payments to Dr. Mehta from 53 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 32% of the total. Bausch Health Americas, Inc. paid the most, $181,514.

Dmand AI lists 1 award for Dr. Mehta, most recently CMS Stage 1 EHR in 2013.

Dr. Mehta graduated from Tufts University School Of Medicine in 2005.

Dr. Mehta is in network with 14 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.